טוען...
(99m)Tc-radiolabeled GE11-modified peptide for ovarian tumor targeting
BACKGROUND: Ovarian cancer is a serious threat for women health and the early diagnosis of this cancer might improves the survival rate of patients. The use of the targeted radiopharmaceuticals could be a non-invasive and logical method for tumor imaging. The aim of this study was to radiolabel GE11...
שמור ב:
| הוצא לאור ב: | Daru |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioMed Central
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414288/ https://ncbi.nlm.nih.gov/pubmed/28464952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40199-017-0179-8 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|